top of page

Produções

Artigos científicos

Toxic and antigenic characterization of Peruvian Micrurus surinamensis coral snake venom

Peruvian Micrurus surinamensis coral snake.png

The C-terminal mutation beyond the catalytic site of brown spider phospholipase D significantly impacts its biological activities

brown spider.png

Partial characterization of Loxosceles anomala (Mello-Leitão, 1917) venom: A brown spider of potential medical concern

Bothrops atrox venom: Biochemical properties and cellular phenotypes of three highly toxic classes of toxins

The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production

Loxosceles amazonica Brown Spider Venom: Insights into Enzymatic Activities, Immunorecognition, and Novel Phospholipase D Isoforms

Protective effects of mesenchymal stromal cell-derived secretome on dermonecrosis induced in rabbits by Loxosceles intermedia spider venom

Divergence in toxin antigenicity and venom enzymes in Tityus melici, a medically important scorpion, despite transcriptomic and phylogenetic affinities with problematic Brazilian species

Simultaneous identification of three clinically relevant peruvian pit vipers by multiplex loop-mediated isothermal amplification (mLAMP)

The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production

Bothrops atrox venom: Biochemical properties and cellular phenotypes of three highly toxic classes of toxins

Comparison of Four Methods of RNA Extraction and cDNA Synthesis from The Venom of Peruvian Snakes of the Genus Bothrops of Clinical Importance

Partial characterization of Loxosceles anomala (Mello-Leitão, 1917) venom: A brown spider of potential medical concern.

The C-terminal mutation beyond the catalytic site of brown spider phospholipase D significantly impacts its biological activities

Toxic and antigenic characterization of Peruvian Micrurus surinamensis coral snake venom

Scorpion envenomation in Brazil: Current scenario and perspectives for containing an increasing health problem

Patentes

Processo para obtenção de proteína recombinante multiepítopo de Loxosceles e uso.
Número do registro: BR020220026866; 2022.

Processo de obtenção de peptídeos analgésicos por meio de Bioinformática e peptídeo obtido.

Número do registro: BR1020220124558; 2022.

Proteina Quimérica Recombinante, DNA e Usos para Produção de Soros antiveneno de Tityus serrulatus

Número do registro: BR1020230277918; 2023.

bottom of page